CN107048259A - 用十三种珍贵食材配制的健康食品及其配制方法 - Google Patents
用十三种珍贵食材配制的健康食品及其配制方法 Download PDFInfo
- Publication number
- CN107048259A CN107048259A CN201710238048.XA CN201710238048A CN107048259A CN 107048259 A CN107048259 A CN 107048259A CN 201710238048 A CN201710238048 A CN 201710238048A CN 107048259 A CN107048259 A CN 107048259A
- Authority
- CN
- China
- Prior art keywords
- parts
- food
- soft
- shelled turtle
- hawthorn
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 38
- 239000000463 material Substances 0.000 title claims abstract description 25
- 235000001497 healthy food Nutrition 0.000 title claims abstract description 16
- 238000000034 method Methods 0.000 title claims description 17
- 150000001875 compounds Chemical class 0.000 title description 5
- 230000000694 effects Effects 0.000 claims abstract description 31
- 241001482311 Trionychidae Species 0.000 claims abstract description 30
- 241001264174 Cordyceps militaris Species 0.000 claims abstract description 28
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 28
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 28
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 28
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 28
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 28
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 28
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 28
- 240000000171 Crataegus monogyna Species 0.000 claims abstract description 28
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 28
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 28
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 28
- 240000002234 Allium sativum Species 0.000 claims abstract description 23
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 23
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 23
- 235000004611 garlic Nutrition 0.000 claims abstract description 23
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims abstract description 22
- 244000077995 Coix lacryma jobi Species 0.000 claims abstract description 20
- 244000197580 Poria cocos Species 0.000 claims abstract description 20
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 20
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 20
- 235000008397 ginger Nutrition 0.000 claims abstract description 20
- 244000241872 Lycium chinense Species 0.000 claims abstract description 19
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 19
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 19
- 244000068988 Glycine max Species 0.000 claims abstract description 18
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 18
- 241001620634 Roger Species 0.000 claims abstract description 18
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 16
- 238000011282 treatment Methods 0.000 claims abstract description 11
- 244000273928 Zingiber officinale Species 0.000 claims abstract description 7
- 239000000843 powder Substances 0.000 claims description 53
- 239000002994 raw material Substances 0.000 claims description 22
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 10
- 230000009286 beneficial effect Effects 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 239000005030 aluminium foil Substances 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 238000004659 sterilization and disinfection Methods 0.000 claims description 5
- 244000241838 Lycium barbarum Species 0.000 claims description 4
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 4
- 235000012054 meals Nutrition 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 3
- 239000006071 cream Substances 0.000 claims description 3
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 claims description 3
- 235000011194 food seasoning agent Nutrition 0.000 claims description 3
- 235000012907 honey Nutrition 0.000 claims description 3
- 229960002591 hydroxyproline Drugs 0.000 claims description 3
- 210000003205 muscle Anatomy 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 238000003307 slaughter Methods 0.000 claims description 3
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 claims description 3
- 210000001835 viscera Anatomy 0.000 claims description 3
- 235000002710 Ilex cornuta Nutrition 0.000 claims description 2
- 241001310146 Ilex cornuta Species 0.000 claims description 2
- 235000010326 Osmanthus heterophyllus Nutrition 0.000 claims description 2
- 238000007689 inspection Methods 0.000 claims description 2
- 244000046052 Phaseolus vulgaris Species 0.000 claims 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims 2
- 244000251953 Agaricus brunnescens Species 0.000 claims 1
- 241000489569 Mandevilla x amabilis Species 0.000 claims 1
- 240000002853 Nelumbo nucifera Species 0.000 claims 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims 1
- 210000004369 blood Anatomy 0.000 abstract description 12
- 239000008280 blood Substances 0.000 abstract description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 12
- 201000010099 disease Diseases 0.000 abstract description 11
- 235000016709 nutrition Nutrition 0.000 abstract description 7
- 230000035764 nutrition Effects 0.000 abstract description 5
- 230000001133 acceleration Effects 0.000 abstract description 2
- 230000009702 cancer cell proliferation Effects 0.000 abstract description 2
- 235000003642 hunger Nutrition 0.000 abstract description 2
- 230000002265 prevention Effects 0.000 abstract description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 14
- 241000234314 Zingiber Species 0.000 description 13
- 230000006870 function Effects 0.000 description 10
- 239000003925 fat Substances 0.000 description 9
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 8
- 229910052711 selenium Inorganic materials 0.000 description 8
- 239000011669 selenium Substances 0.000 description 8
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 7
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 7
- 239000011575 calcium Substances 0.000 description 7
- 229910052791 calcium Inorganic materials 0.000 description 7
- 235000001465 calcium Nutrition 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 230000036541 health Effects 0.000 description 7
- 229910052742 iron Inorganic materials 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- 239000011574 phosphorus Substances 0.000 description 7
- 229910052698 phosphorus Inorganic materials 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 150000001413 amino acids Chemical class 0.000 description 6
- 201000011510 cancer Diseases 0.000 description 6
- 230000036039 immunity Effects 0.000 description 6
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 5
- 244000303040 Glycyrrhiza glabra Species 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 5
- 230000001093 anti-cancer Effects 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 231100000614 poison Toxicity 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 229960003495 thiamine Drugs 0.000 description 5
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 5
- 239000011701 zinc Substances 0.000 description 5
- 229910052725 zinc Inorganic materials 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- 240000002624 Mespilus germanica Species 0.000 description 4
- 235000017784 Mespilus germanica Nutrition 0.000 description 4
- 235000000560 Mimusops elengi Nutrition 0.000 description 4
- 235000007837 Vangueria infausta Nutrition 0.000 description 4
- 229930003451 Vitamin B1 Natural products 0.000 description 4
- 206010047700 Vomiting Diseases 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 4
- 230000003712 anti-aging effect Effects 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- 150000001720 carbohydrates Chemical class 0.000 description 4
- 235000014633 carbohydrates Nutrition 0.000 description 4
- 238000002512 chemotherapy Methods 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 230000002496 gastric effect Effects 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 239000011573 trace mineral Substances 0.000 description 4
- 235000013619 trace mineral Nutrition 0.000 description 4
- -1 triterpene compound Chemical class 0.000 description 4
- 235000010374 vitamin B1 Nutrition 0.000 description 4
- 239000011691 vitamin B1 Substances 0.000 description 4
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 3
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 3
- 241001248610 Ophiocordyceps sinensis Species 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- 210000001744 T-lymphocyte Anatomy 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000000306 component Substances 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 229940029982 garlic powder Drugs 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 229940010454 licorice Drugs 0.000 description 3
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 235000008935 nutritious Nutrition 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 238000001959 radiotherapy Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 230000004614 tumor growth Effects 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 description 2
- 229930195730 Aflatoxin Natural products 0.000 description 2
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 2
- 241001107116 Castanospermum australe Species 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- KQLDDLUWUFBQHP-UHFFFAOYSA-N Cordycepin Natural products C1=NC=2C(N)=NC=NC=2N1C1OCC(CO)C1O KQLDDLUWUFBQHP-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 235000017443 Hedysarum boreale Nutrition 0.000 description 2
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 208000001953 Hypotension Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000034189 Sclerosis Diseases 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 229960005305 adenosine Drugs 0.000 description 2
- 239000005409 aflatoxin Substances 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 235000021279 black bean Nutrition 0.000 description 2
- 235000005473 carotenes Nutrition 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- OFEZSBMBBKLLBJ-BAJZRUMYSA-N cordycepin Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)C[C@H]1O OFEZSBMBBKLLBJ-BAJZRUMYSA-N 0.000 description 2
- OFEZSBMBBKLLBJ-UHFFFAOYSA-N cordycepine Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)CC1O OFEZSBMBBKLLBJ-UHFFFAOYSA-N 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 2
- 229960001340 histamine Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 208000021822 hypotensive Diseases 0.000 description 2
- 230000001077 hypotensive effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 2
- 235000008696 isoflavones Nutrition 0.000 description 2
- 201000002364 leukopenia Diseases 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 239000003176 neuroleptic agent Substances 0.000 description 2
- 230000000701 neuroleptic effect Effects 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- XKLJHFLUAHKGGU-UHFFFAOYSA-N nitrous amide Chemical compound ON=N XKLJHFLUAHKGGU-UHFFFAOYSA-N 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 231100000572 poisoning Toxicity 0.000 description 2
- 230000000607 poisoning effect Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 150000003505 terpenes Chemical class 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- UPJVQRZPXLZUET-UHFFFAOYSA-N (10R)-3c,5t,8t-Trihydroxy-10r,13c-dimethyl-17c-((1R:4R)-1,4,5-trimethyl-hexen-(2t)-yl)-(9tH,14tH)-Delta6-tetradecahydro-1H-cyclopenta[a]phenanthren Natural products OC12C=CC3(O)CC(O)CCC3(C)C2CCC2(C)C1CCC2C(C)C=CC(C)C(C)C UPJVQRZPXLZUET-UHFFFAOYSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- JDLKFOPOAOFWQN-VIFPVBQESA-N Allicin Natural products C=CCS[S@](=O)CC=C JDLKFOPOAOFWQN-VIFPVBQESA-N 0.000 description 1
- XUHLIQGRKRUKPH-GCXOYZPQSA-N Alliin Natural products N[C@H](C[S@@](=O)CC=C)C(O)=O XUHLIQGRKRUKPH-GCXOYZPQSA-N 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 201000000274 Carcinosarcoma Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 102000001189 Cyclic Peptides Human genes 0.000 description 1
- 108010069514 Cyclic Peptides Proteins 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000032928 Dyslipidaemia Diseases 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010018473 Glycosuria Diseases 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 208000034767 Hypoproteinaemia Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 108010002350 Interleukin-2 Proteins 0.000 description 1
- 102000000588 Interleukin-2 Human genes 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 229920001491 Lentinan Polymers 0.000 description 1
- 229930194248 Licoflavone Natural products 0.000 description 1
- MEHHCBRCXIDGKZ-UHFFFAOYSA-N Licoflavone C Natural products CC(C)=CCC1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=C(O)C=C1 MEHHCBRCXIDGKZ-UHFFFAOYSA-N 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 241000736919 Pelodiscus sinensis Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- XUHLIQGRKRUKPH-UHFFFAOYSA-N S-allyl-L-cysteine sulfoxide Natural products OC(=O)C(N)CS(=O)CC=C XUHLIQGRKRUKPH-UHFFFAOYSA-N 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 208000021386 Sjogren Syndrome Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000018742 Vitex negundo var cannabifolia Nutrition 0.000 description 1
- 244000271612 Vitex negundo var. cannabifolia Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- LPQOADBMXVRBNX-UHFFFAOYSA-N ac1ldcw0 Chemical compound Cl.C1CN(C)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN3CCSC1=C32 LPQOADBMXVRBNX-UHFFFAOYSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000000240 adjuvant effect Effects 0.000 description 1
- 230000001780 adrenocortical effect Effects 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- JDLKFOPOAOFWQN-UHFFFAOYSA-N allicin Chemical group C=CCSS(=O)CC=C JDLKFOPOAOFWQN-UHFFFAOYSA-N 0.000 description 1
- 235000010081 allicin Nutrition 0.000 description 1
- XUHLIQGRKRUKPH-DYEAUMGKSA-N alliin Chemical compound OC(=O)[C@@H](N)C[S@@](=O)CC=C XUHLIQGRKRUKPH-DYEAUMGKSA-N 0.000 description 1
- 235000015295 alliin Nutrition 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 208000019065 cervical carcinoma Diseases 0.000 description 1
- 239000013064 chemical raw material Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- MDZKJHQSJHYOHJ-UHFFFAOYSA-N crataegolic acid Natural products C1C(O)C(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MDZKJHQSJHYOHJ-UHFFFAOYSA-N 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- MCWXGJITAZMZEV-UHFFFAOYSA-N dimethoate Chemical compound CNC(=O)CSP(=S)(OC)OC MCWXGJITAZMZEV-UHFFFAOYSA-N 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- VXOZCESVZIRHCJ-KGHQQZOUSA-N ergosterol peroxide Chemical compound O1O[C@@]2(C=C3)[C@@H]4CC[C@H]([C@H](C)/C=C/[C@H](C)C(C)C)[C@@]4(C)CC[C@@H]2[C@]2(C)[C@@]13C[C@@H](O)CC2 VXOZCESVZIRHCJ-KGHQQZOUSA-N 0.000 description 1
- VXOZCESVZIRHCJ-KYQKSOQPSA-N ergosterol peroxide Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@@H]2[C@]1(C)CC[C@@H]3[C@@]4(C)CC[C@H](O)C[C@@]45OO[C@@]23C=C5 VXOZCESVZIRHCJ-KYQKSOQPSA-N 0.000 description 1
- LESGHGUKCRHTCP-UHFFFAOYSA-N ergosteryl peroxide Natural products C1C(OO)CCC2(C)C(CCC3(C(C(C)C=CC(C)C(C)C)CCC33)C)C3=CC=C21 LESGHGUKCRHTCP-UHFFFAOYSA-N 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005428 food component Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 230000002070 germicidal effect Effects 0.000 description 1
- NLDDIKRKFXEWBK-AWEZNQCLSA-N gingerol Chemical compound CCCCC[C@H](O)CC(=O)CCC1=CC=C(O)C(OC)=C1 NLDDIKRKFXEWBK-AWEZNQCLSA-N 0.000 description 1
- JZLXEKNVCWMYHI-UHFFFAOYSA-N gingerol Natural products CCCCC(O)CC(=O)CCC1=CC=C(O)C(OC)=C1 JZLXEKNVCWMYHI-UHFFFAOYSA-N 0.000 description 1
- 235000002780 gingerol Nutrition 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 150000002337 glycosamines Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 235000008085 high protein diet Nutrition 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 229940047122 interleukins Drugs 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 229940115286 lentinan Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000002366 lipolytic effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- MDZKJHQSJHYOHJ-LLICELPBSA-N maslinic acid Chemical compound C1[C@@H](O)[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MDZKJHQSJHYOHJ-LLICELPBSA-N 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000001613 neoplastic effect Effects 0.000 description 1
- VIKNJXKGJWUCNN-XGXHKTLJSA-N norethisterone Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 VIKNJXKGJWUCNN-XGXHKTLJSA-N 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 210000003024 peritoneal macrophage Anatomy 0.000 description 1
- 239000003075 phytoestrogen Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- 208000005333 pulmonary edema Diseases 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- GGYFMLJDMAMTAB-UHFFFAOYSA-N selanylidenelead Chemical compound [Pb]=[Se] GGYFMLJDMAMTAB-UHFFFAOYSA-N 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 108010028621 stem cell inhibitory factor Proteins 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- CEIZFXOZIQNICU-UHFFFAOYSA-N tenuazonic acid Chemical compound CCC(C)C1NC(=O)C(C(C)=O)=C1O CEIZFXOZIQNICU-UHFFFAOYSA-N 0.000 description 1
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- DLFVBJFMPXGRIB-UHFFFAOYSA-N thioacetamide Natural products CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明用甲鱼、拟黑多刺蚁、蛹虫草、茯苓、山楂、香菇、枸杞子、薏苡仁、葛根、甘草、黑豆、大蒜、生姜等十三种珍贵食材配制的健康食品,方便肿瘤患者营养充饥、使之气血充沛、体质强壮、顺利接受继续治疗,加速恢复健康,在治疗肿瘤及防止其癌细胞扩散方面发挥一定的作用。本发明为肿瘤病人的身体康复和辅助治疗提供的健康食品也可供高危人群补充营养预防疾病,具有巨大的市场需求。
Description
技术领域
本发明涉及食品领域,具体涉及一种用甲鱼、拟黑多刺蚁、蛹虫草、茯苓、山楂、香菇、枸杞子、薏苡仁、葛根、甘草、黑豆、大蒜、生姜等十三种珍贵食材配制的健康食品及其配制方法。
背景技术
健康食品是食品的一个种类,具有一般食品的共性,其原材料也主要取自天然的动植物,经先进生产工艺加工,将其所含丰富的功效成分作用发挥到极至,从而能调节人体机能,适用于有特定功能需求的相应人群食用的特殊食品。恶性肿瘤是严重危害人类健康和生命的疾病,其发病率逐年上升。现在临床上一般都采用化疗、放疗、手术等治疗方法,虽能取得一定疗效,可以延长患者生命或恢复健康,但这些疗法大多会导致人体正气受到损害,出现气血不足、倦怠乏力、头晕目眩、恶心呕吐、食欲不振等症。肿瘤病人身体康复需求的食品就是一种特殊食品,必须少而精口感好、营养元素丰富、易于消化吸收。现在肿瘤病人在化疗、放疗和手术前后往往听取医生的建议,让家属或陪护买一些甲鱼和食材煲汤配合治疗,但是由于不会加工甲鱼或食材选择、配比不当,不能达到理想的食疗效果。病人也由于消化功能减弱,对甲鱼汤等高蛋白食物难于接受。本发明人经过反复研究,针对这一人群选用了十三种珍贵食材配制一种健康食品,目的在于不仅方便患者能营养充饥、使之气血充沛、体质强壮、顺利接受继续治疗,加速恢复健康、预防因其体质虚弱而导致病邪易于侵犯、发生其它疾病,而且在治疗肿瘤及防止其癌细胞扩散方面发挥一定的作用。本发明供肿瘤病人身体康复和辅助治疗及高危人群营养保健具有巨大市场需求。
发明内容
本发明针对上述问题,提供一种用甲鱼、拟黑多刺蚁、蛹虫草、茯苓、山楂、香菇、枸杞子、薏苡仁、葛根、甘草、黑豆、大蒜、生姜等十三种珍贵食材配制的健康食品及其制备方法。
一种用甲鱼、拟黑多刺蚁、蛹虫草、茯苓、山楂、香菇、枸杞子、薏苡仁、葛根、甘草、黑豆、大蒜、生姜等十三种珍贵食材配制的健康食品及其制备方法,其特征在于,甲鱼是采用原料烘干粉10-12份和酶解活性肽干粉1-3份;香菇4-6份、葛根18-20份、大蒜0.5-1.5份、生姜0.5-1.5份采用原料烘干粉;拟黑多刺蚁4-6份、蛹虫草4-6份、茯苓4-6份、山楂4-6份、枸杞子4-6份、薏苡仁4-6份、甘草4-6份、黑豆4-6份采用10∶1的原料提取物。甲鱼烘干粉含粗蛋白60%以上、灰分22%左右、细度>120目;酶解活性肽干粉来源为采用本发明人的发明专利技术生产(申请号201611005588.5《一种中华鳖酶解物配制保健食品及其制备方法》)。香菇、葛根、大蒜、生姜采用原料烘干粉有利于保留这些食材的色、香、味;拟黑多刺蚁、蛹虫草、茯苓、山楂、枸杞子、薏苡仁、甘草、黑豆采用10∶1的原料提取物,有利于汲取精华、减少体积和易于消化。
甲鱼肉味鲜美,每百克肉含蛋白质16.5克、脂肪、硒和钙、磷、铁等,营养价值很高,是滋补珍品。中医认为,甲鱼的主要功能是滋阴养血,还有软坚散结的作用,最适合于阴虚内热的人食用。适宜体质衰弱、肝肾阴虚、骨蒸劳热、营养不良之人食用;适宜肺结核及肺外结核低烧不退之人食用;适宜慢性肝炎、肝硬化腹水、肝脾肿大、糖尿病、以及肾炎水肿之人食用;适宜各种类型的癌症患者及放疗、化疗后食用;适宜干燥综合征患者食用;适宜高血脂、动脉硬化、冠心病、高血压患者食用;适宜低蛋白血症患者、脚气病患者食用。拟黑多刺蚁是经卫生部批准的唯一有药、食两用价值的蚂蚁,其体内含有70多种营养成份,含42-67%的蛋白质,28种游离氨基酸(包括人体必须的8种氨基酸);含维生素B1、B2、B12、C、D、E等;含钙、铁、磷、锰、硒、锌等20多种微量元素,特别是被誉为“生命火花’锌的含量最为丰富,每千克含锌达120-198毫克;含三萜类化合物、蚁酸、三磷酸腺苷(ATP)及人工无法合成的草体蚁醛、白细胞介素-2等多种生物活性物质,其含量在百万种动、植物中名列前茅。三萜类化合物有止痛、镇静、抑制组织胺释放、解毒、保肝、毒杀肿瘤细胞等功能,有显著的降血压和降血脂作用,同时对肝肉瘤等肿瘤细胞也有抑制作用,是抗癌最好的物质;对高血压、高血脂、失眠和多种呼吸系统疾病(如去痰、止咳、平喘)有很好的治疗作用。白细胞介素是一种有免疫活性的物质,过去称为T细胞生长因子。它能增强T淋巴细胞及自然杀伤细胞(NK)的活性,具有增强机体免疫功能、活化细胞因子、遏制细胞恶变和抗病毒作用。蛹虫草化学成份:N6-[β-(乙酰胺甲酰)氧乙基]腺苷;虫草环肽A;核苷;麦角甾醇过氧化物。蛹虫草药理作用:现代科学论证蛹虫草不仅具有特殊的营养价值,而且有明显的药用价值。其中尤以虫草酸、虫草素、虫草多糖。蛹虫草中的虫草素,可抗病毒、抗菌、明显抑制肿瘤生长、干扰人体RNA及DNA合成。蛹虫草富含虫草酸,虫草酸能有效预防治疗脑血栓、脑溢血、肾功能衰竭,同时还具有利尿作用。蛹虫草中的腺苷,可以抗病毒、抗菌,抑制血小板积聚防治血栓形成,还可消除面斑,抗衰防皱。蛹虫草中虫草多糖,有提高免疫力,延缓衰老,扶正固本,保护心脏、肝脏,肾脏的作用。蛹虫草中的麦角甾醇、超氧化物歧化酶,对抑制或消除催人衰老的超氧自由基形成及抗癌、防衰、减低毒害有良好作用。蛹虫草还富含硒,大量的科学实践证明硒可以明显地抑制癌细胞的生长,刺激免疫球蛋白和抗体的产生,增强机体免疫和抗氧化能力。茯苓的主要成分为茯苓聚糖,含量很高。对多种细菌有抑制作用;能降胃酸,对消化道溃疡有预防效果;对肝损伤有明显的保护作用;有抗肿瘤的作用;能多方面对免疫功能进行调节;能使化疗所致白细胞减少加速回升;并有镇静作用。
山楂中含有的营养物质是非常多的,山楂中含有多种维生素、山楂酸、柠檬酸、苹果酸、糖类、钙、铁、磷等多种营养物质,山楂中含有的解脂酶还能促进脂肪类的食物消化,山楂还能促进胃液分泌和增加胃内酶素等功能。山楂具有消积化滞、收敛止痢、活血化淤等功效。山楂中含有的山萜类及黄酮类具有显著的扩张血管及降血压的作用,经常吃山楂还具有坚强心肌、抗心律不齐、调节血压及胆固醇的功能。最新研究发现山楂中含有一种牡荆素的化合物,这种物质就有抗癌的作用。亚硝胺和黄曲霉素都可能诱发消化道癌症的发生,在山楂中提取的汁液不仅能阻断亚硝胺的合成,还可以抑制黄曲霉素的致癌作用。如果人体出现消化不良的问题,食用山楂可以帮助消化,能起到辅助抗癌作用。香菇是具有高蛋白、低脂肪、多糖、多种氨基酸和多种维生素的菌类食物。提高机体免疫功能:香菇多糖可提高小鼠腹腔巨噬细胞的吞噬功能,还可促进T淋巴细胞的产生,并提高T淋巴细胞的杀伤活性。延缓衰老:香菇的水提取物对过氧化氢有清除作用,对体内的过氧化氢有一定的消除作用。防癌抗癌:香菇菌盖部分含有双链结构的核糖核酸,进入人体后,会产生具有抗癌作用的干扰素。香菇中含有嘌呤、胆碱、酪氨酸、氧化酶以及某些核酸物质,能起到降血压、降胆固醇、降血脂的作用,又可预防动脉硬化、肝硬化等疾病。对糖尿病、肺结核、传染性肝炎、神经炎等起治疗作用,又可用于消化不良、便秘等。枸杞子味甘性平,归肝、肾经。其具有滋补肝肾,益精养血,明目消翳,润肺止咳的作用。现代研究测定枸杞子提取液中的有效成分,发现含有丰富的下列物质:枸杞多糖、单糖、甜菜碱、脂肪酸、蛋白质和多肽、维生素B1、维生素B2、维生素C、18种氨基酸(含8种必需氨基酸)、微量元素(钙、锌、镁、铁、锰、磷等)。此外,据最新出版的中国食物成分表记载,枸杞中胡萝卜素含量显著高于水果蔬菜,还含有维生素E、维生素D、磷脂及硒等成分。药理学研究证实,枸杞子可调节机体免疫功能、能有效抑制肿瘤生长和细胞突变、具有延缓衰老、抗脂肪肝、调节血脂和血糖等方面的作用。枸杞子对糖尿病、血脂异常症、肝功能异常、胃炎等都有一定的治疗作用。体外试验表明,枸杞子、叶对人胃腺癌KATo-III细胞,枸杞果柄、叶对人宫颈癌Hela细胞均有明显抑制作用,其作用机理主要表现在抑制细胞DNA合成,干扰细胞分裂,细胞再殖能力下降。枸杞子冻干粉混悬液和环磷酰胺联合用药,治疗大鼠Walker癌肉瘤256,发现其对环磷酰胺导致的白细胞减少有明显保护作用。
薏苡仁是养生药用佳品。据医药部门化验分析,薏米含蛋白质16.2%,脂肪4.6%,糖类79.2%。李时珍在《本草纲目》中记载:薏米能″健脾益胃,补肺清热,去风渗湿。炊饭食,治冷气。煎饮,利小便热淋。″近年来,大量的科学研究和临床实践证明,薏苡仁还是一种抗癌药物,初步鉴定,它对癌症的抑制率可达35%以上。抗肿瘤尤以脾虚湿盛的消化道肿瘤及痰热挟湿的肺癌更为适宜。
葛根粉含12%的黄酮类化合物,如葛根素、大豆黄酮苷、花生素等营养成分,还有蛋白质、氨基酸、糖、和人体必需的铁、钙、铜、硒等矿物质,是老少皆宜的名贵滋补品,有″千年人参″之美誉。既有药用价值,又有营养保健之功效。葛根具有清腻解热,祛痰止咳,降血糖的作用,保护心脑血管健康;含有大量的膳食纤维,能改善便秘,清除体内毒素,减少癌病的发生;解酒、养胃、保肝、护肝;常食葛根粉能调节人体机能,增强体质,提高机体抗病能力,抗衰延年;葛根异黄酮具有较高的植物雌激素,可激活卵巢活力使皮肤光滑细嫩。甘草有解毒、祛痰、止痛、解痉以至抗癌等药理作用。甘草补脾益气,止咳润肺,缓急解毒,调和百药。甘草有类似肾上腺皮质激素样作用,对组胺引起的胃酸分泌过多有抑制作用;并有抗酸和缓解胃肠平滑肌痉挛作用。甘草黄酮、甘草浸膏及甘草次酸均有明显的镇咳作用;祛痰作用也较显著,甘草还有抗炎,抗过敏作用,能保护发炎的咽喉和气管粘膜。甘草浸膏和甘草酸对某些毒物有类似葡萄糖醛酸的解毒作用。甘草常用来治疗随更年期而来的症状.因为甘草里含有甘草素,是一种类似激素的化合物,它有助于平衡女性体内的激素含量。甘草所含的次酸能阻断致癌物诱发肿瘤生长的作用。
黑豆富含对人体有益的氨基酸、不饱和脂肪酸及钙、磷等多种微量元素。有排脓拔毒、消肿止痛等功效,并有益于防治高血压、高血脂、心脏病等疾病。黑豆营养丰富,每百克含蛋白质36.1克、脂肪15.9克、膳食纤维10.2克、碳水化合物23.3克、钙224毫克、镁243毫克、钾1377毫克、磷500毫克,还含有人体必需的维生素B1、B2、C、烟酸和微量元素铁、锰、锌、铜、钼、硒等。研究表明,黑豆中的异黄酮是一种植物性雌激素,能有效抑制乳腺癌、前列腺癌和结肠癌,对防治中老年骨质疏松也很有帮助。
大蒜营养丰富:每100克含水分69.8克,蛋白质4.4克,脂肪0.2克,碳水化合物23.6克,钙5毫克,磷44毫克,铁0.4毫克,维生素C3毫克。此外,还含有硫胺素、核黄素、尼克酸、蒜素、柠檬醛以及硒和锗等微量元素。含挥发油约0.2%,油中主要成分为大蒜辣素,是大蒜中所含的蒜氨酸受大蒜酶的作用水解产生。尚含多种烯丙基、丙基和甲基组成的硫醚化合物等。大蒜具有强大的杀菌能力,能消灭侵入体内的病菌。它还有助维生素B1的吸收,促进糖类的新陈代谢以产生能量,并缓解疲劳。大蒜另一个不可忽视的功用就是提升免疫力,其中所含的硒化铅还具有抗氧化作用,蒜中含有“蒜胺”,这种物质对大脑的益处比维生素B,还强许多倍。
生姜其特有的“姜辣素”能刺激胃肠黏膜,使胃肠道充血,消化能力增强,能有效地治疗吃寒凉食物过多而引起的腹胀、腹痛、腹泻、呕吐等。用于脾胃虚寒,食欲减退,恶心呕吐,或痰饮呕吐,胃气不和的呕吐;抗氧化,抑制肿瘤。
一种用甲鱼、拟黑多刺蚁、蛹虫草、茯苓、山楂、香菇、枸杞子、薏苡仁、葛根、甘草、黑豆、大蒜、生姜等十三种珍贵食材配制的健康食品及其制备方法,其特征在于,具体加工步骤如下:
1.制备甲鱼烘干粉和酶解活性肽:甲鱼宰杀后采用蒸汽恒温烘干肌肉和背甲,经过超细微粉碎,细度均达到120目以上;其纯度为100%,不添加任何成份;羟脯氨酸含量高达2.6%;甲鱼的内脏下脚等酶解后,浓缩、干燥、粉碎备用。
2.采购香菇、葛根、大蒜、生姜原料烘干粉,产品质量符合国家食品卫生标准。
3.采购拟黑多刺蚁、蛹虫草、茯苓、山楂、枸杞子、薏苡仁、甘草、黑豆10∶1的原料提取物,细度均达到120目以上,产品质量符合国家食品卫生标准。
4.混合加工成健康食品:把用甲鱼、拟黑多刺蚁、蛹虫草、茯苓、山楂、香菇、枸杞子、薏苡仁、葛根、甘草、黑豆、大蒜、生姜等十三种珍贵食材制备的原料按照配方比例混合均匀,干燥灭菌,检验合格用食品级铝箔袋密封包装即成。
5.食用方法:每次一袋30-50克,倒入碗里用90℃以上的开水冲调成膏滋状或稀糊,可根据个人需要适量加蜂蜜或食糖、食盐调味,每日1-2餐。
与现有技术和应用方法相比,本发明十三种食材配制健康食品有益效果是:
1.本发明根据我国传统养生药膳食疗理论和现代营养科研最新成果,采用甲鱼、拟黑多刺蚁、蛹虫草、茯苓、山楂、香菇、枸杞子、薏苡仁、葛根、甘草、黑豆、大蒜、生姜等十三种珍贵食材配制的健康食品,具有营养丰富,口感良好,易于消化等优点,为肿瘤病人的身体康复和辅助治疗提供了有益帮助。
2.本发明配制方法合理,设备投入不多,容易复制推广和产业化。把甲鱼等十三种珍贵食材经先进生产工艺加工,将其所含丰富的营养成分作用发挥到极至。
3.本发明全部采用国家批准的动植物食材原料,产品中不添加药材和化学原料。
具体实施方式
下面结合实施例对本发明作进一步说明,以下记载的仅为本发明的优选实施例,当然不能以此来限定本发明之权利范围,因此依本发明权利要求所作的等同变化,仍属本发明所涵盖的范围。
1.制备甲鱼烘干粉和酶解活性肽:甲鱼宰杀后采用蒸汽恒温烘干肌肉和背甲,经过超细微粉碎,细度均达到120目以上;其纯度为100%,不添加任何成份;羟脯氨酸含量高达2.6%;甲鱼的内脏等原料酶解后,浓缩、干燥、粉碎备用。
2.采购香菇、葛根、大蒜、生姜原料烘干粉,产品质量符合国家食品卫生标准。
3.采购拟黑多刺蚁、蛹虫草、茯苓、山楂、枸杞子、薏苡仁、甘草、黑豆10∶1的原料提取物,细度均达到120目以上,产品质量符合国家食品卫生标准。
实施例一:
采用制备好的甲鱼原料烘干粉10份和酶解活性肽干粉1份;用采购的香菇原料烘干粉4份、葛根粉18份、大蒜粉0.5份、生姜粉0.5份;用采购的10∶1的原料提取物拟黑多刺蚁粉4份、蛹虫草粉4份、茯苓粉4份、山楂粉4份、枸杞子粉4份、薏苡仁粉4份、甘草粉4份、黑豆粉4份,按照配方比例混合均匀,干燥灭菌,检验合格后用食品级铝箔袋密封包装,每袋50克,即成。
实施例二:
采用制备好的甲鱼原料烘干粉11份和酶解活性肽干粉2份;用采购的香菇原料烘干粉5份、葛根粉19份、大蒜粉1份、生姜粉1份;用采购的10∶1的原料提取物拟黑多刺蚁粉5份、蛹虫草粉5份、茯苓粉5份、山楂粉5份、枸杞子粉5份、薏苡仁粉5份、甘草粉5份、黑豆粉5份,按照配方比例混合均匀,干燥灭菌,检验合格后用食品级铝箔袋密封包装,每袋40克,即成。
实施例三:
采用制备好的甲鱼原料烘干粉12份和酶解活性肽干粉3份;用采购的香菇原料烘干粉6份、葛根粉20份、大蒜粉1.5份、生姜粉1.5份;用采购的10∶1的原料提取物拟黑多刺蚁粉6份、蛹虫草粉6份、茯苓粉6份、山楂粉6份、枸杞子粉6份、薏苡仁粉6份、甘草粉6份、黑豆粉6份,按照配方比例混合均匀,干燥灭菌,检验合格后用食品级铝箔袋密封包装,每袋30克,即成。食用方法:每次一袋30-50克,倒入碗里用90℃以上的开水冲调成膏滋状或稀糊,可根据个人需要适量加蜂蜜或食糖、食盐调味,每日吃1-2餐。本品口感较好,易于消化,可为肿瘤病人的身体康复和辅助治疗提供有益帮助,也可以供高危人群补充营养、提高免疫能力。通过长期的实验观察,食用者反映良好,受到医生、患者和家属一致好评。
Claims (3)
1.一种用甲鱼、拟黑多刺蚁、蛹虫草、茯苓、山楂、香菇、枸杞子、薏苡仁、葛根、甘草、黑豆、大蒜、生姜等十三种珍贵食材配制的健康食品及其制备方法,其特征在于,甲鱼是采用原料烘干粉10-12份和酶解活性肽干粉1-3份;香菇4-6份、葛根18-20份、大蒜05-1.5份、生姜0.5-1.5份采用原料烘干粉;拟黑多刺蚁4-6份、蛹虫草4-6份、茯苓4-6份、山楂4-6份、枸杞子4-6份、薏苡仁4-6份、甘草4-6份、黑豆4-6份采用10∶1的原料提取物。
2.一种用甲鱼、拟黑多刺蚁、蛹虫草、茯苓、山楂、香菇、枸杞子、薏苡仁、葛根、甘草、黑豆、大蒜、生姜等十三种珍贵食材配制健康食品的制备方法,其特征在于,具体加工步骤如下:
A.制备甲鱼烘干粉和酶解活性肽:甲鱼宰杀后采用蒸汽恒温烘干肌肉和背甲,经过超细微粉碎,细度均达到120目以上;其纯度为100%,不添加任何成份;羟脯氨酸含量高达2.6%;甲鱼的内脏下脚等酶解后,浓缩、干燥、粉碎备用。
B.采购香菇、葛根、大蒜、生姜原料烘干粉,产品质量符合国家食品卫生标准。
C.采购拟黑多刺蚁、蛹虫草、茯苓、山楂、枸杞子、薏苡仁、甘草、黑豆10∶1的原料提取物,细度均达到120目以上,产品质量符合国家食品卫生标准。
D.混合加工成健康食品:把用甲鱼、拟黑多刺蚁、蛹虫草、茯苓、山楂、香菇、枸杞子、薏苡仁、葛根、甘草、黑豆、大蒜、生姜等十三种珍贵食材制备的原料按照配方比例混合均匀,干燥灭菌,检验合格用食品级铝箔袋密封包装即成。
3.如权利要求1所述,本发明的食用方法是:每次一袋30-50克,倒入碗里用90℃以上的开水冲调成膏滋状或稀糊,可根据个人需要适量添加蜂蜜或食糖、食盐调味,每日1-2餐,为肿瘤病人的身体康复和辅助治疗提供有益帮助。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710238048.XA CN107048259A (zh) | 2017-04-07 | 2017-04-07 | 用十三种珍贵食材配制的健康食品及其配制方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710238048.XA CN107048259A (zh) | 2017-04-07 | 2017-04-07 | 用十三种珍贵食材配制的健康食品及其配制方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107048259A true CN107048259A (zh) | 2017-08-18 |
Family
ID=59601961
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710238048.XA Pending CN107048259A (zh) | 2017-04-07 | 2017-04-07 | 用十三种珍贵食材配制的健康食品及其配制方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107048259A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109938272A (zh) * | 2019-03-07 | 2019-06-28 | 江西共青江中食疗科技有限公司 | 一种具有抑癌抗瘤作用的食疗米糊及其制备方法 |
-
2017
- 2017-04-07 CN CN201710238048.XA patent/CN107048259A/zh active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109938272A (zh) * | 2019-03-07 | 2019-06-28 | 江西共青江中食疗科技有限公司 | 一种具有抑癌抗瘤作用的食疗米糊及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101023802A (zh) | 全营养绿色保健粉(丝、条)和方便(速食)粉(丝、条)系列产品及其制作方法 | |
CN1454500A (zh) | 一种药膳面及制备方法 | |
CN102144748A (zh) | 具有排毒护肝养颜功能的五色面制食品 | |
CN107114663A (zh) | 一种果蔬养胃米粉及其制备方法 | |
CN102178183A (zh) | 一种五豆综合营养食品 | |
CN108887564A (zh) | 一种硒蛋白杂粮粉配方及其制备方法 | |
CN102784162A (zh) | 一种食用菌类复合多糖养生保健治疗剂 | |
CN105533688A (zh) | 一种辅助降血糖保健软胶囊及其制备方法 | |
CN106937741A (zh) | 一种脱脂亚麻籽粉防癌抗癌健康减肥法及其制备方法 | |
CN105995303A (zh) | 一种红参饮品及其制备方法 | |
CN103535600A (zh) | 一种包含杂粮功能性成分的食品及制作工艺 | |
CN109275856A (zh) | 一种灵芝食品 | |
CN111184176A (zh) | 基于体质学说用于九种不同体质的速食型养生食品组合物 | |
CN110583974A (zh) | 一种瘦身全谷营养健康代餐食品及其制备方法 | |
CN112155159A (zh) | 一种健康面粉的制备方法 | |
CN101991110B (zh) | 野生灵芝系列食品 | |
CN111771970A (zh) | 有助于养胃、护胃的组合物及其制备方法 | |
CN101703223B (zh) | 灵芝血耳羹及其制备方法 | |
CN110638038A (zh) | 一种用于控制高血糖的医学配方营养代餐粉及其制备方法 | |
CN107048259A (zh) | 用十三种珍贵食材配制的健康食品及其配制方法 | |
CN113749152A (zh) | 一种健康养生强身饮品及其制备方法 | |
CN106173822A (zh) | 高级人参果孕妇月子营养粉 | |
CN110584037A (zh) | 一种食品人参膏及其制备方法 | |
CN111588029A (zh) | 一种黄精膏组合物 | |
CN111849688A (zh) | 一种养生酒及其制作工艺 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170818 |